Malaysia chosen to test Remdesivir to treat COVID-19 patients
PUTRAJAYA, March 28 (NNN-BERNAMA) — Malaysia is among several countries selected by the World Health Organization (WHO) to carry out the clinical trial on the use of the novel antiviral medicine, Remdesivir, on COVID-19 patients.
Health director-general Dr Noor Hisham Abdullah said Malaysia was chosen for the trial because of the Health Ministry’s ability to conduct tests and its good medical system.